GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 717 filers reported holding GLAXOSMITHKLINE PLC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,380,635,000 | -30.7% | 108,030 | -31.0% | 0.72% | -35.3% |
| Q4 2015 | $6,320,835,000 | +6.1% | 156,650 | +1.1% | 1.11% | +3.2% |
| Q3 2015 | $5,959,677,000 | -34.8% | 154,998 | -29.3% | 1.07% | -31.5% |
| Q2 2015 | $9,135,827,000 | -3.4% | 219,348 | +7.0% | 1.57% | +34.6% |
| Q1 2015 | $9,459,636,000 | +24.4% | 204,976 | +15.2% | 1.16% | -17.3% |
| Q4 2014 | $7,606,803,000 | +9.7% | 177,979 | +18.0% | 1.41% | -0.7% |
| Q3 2014 | $6,931,159,000 | +4.3% | 150,776 | +21.3% | 1.42% | +10.2% |
| Q2 2014 | $6,646,954,000 | +17.8% | 124,289 | +17.6% | 1.29% | +5.0% |
| Q1 2014 | $5,644,552,000 | +17.8% | 105,644 | +17.7% | 1.23% | +16.2% |
| Q4 2013 | $4,791,700,000 | +19.9% | 89,749 | +12.7% | 1.06% | +10.2% |
| Q3 2013 | $3,995,108,000 | +15.5% | 79,631 | +15.1% | 0.96% | +2.7% |
| Q2 2013 | $3,457,495,000 | – | 69,191 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |